Glossary Term Name
This is a placeholder for glossary term definitions.
Research News in Your E-Mail Inbox
JDRF's Research Frontline e-mail newsletter is published approximately 6 to 8 times per year to provide the latest information about research on type 1 diabetes and its complications. The newsletter is available in HTML format, with links to additional information and a printer-friendly Adobe Acrobat version.
Read the current issue:
Read previous issues:
October 2009
* Targeting the B cell prevents diabetes in mice
* Successful encapsulation of beta cell precursors
* Why beta cell regeneration slows with age
* With the switch of a gene, non-insulin producing cells make insulin
August 2009
* Connecting people with diabetes to clinical trials
* Two drugs for hypertension may address diabetic retinopathy
* In development: A novel oral vaccine for type 1 autoimmunity
* JDRF, GNF form innovative partnership
* Researchers gather to discuss the complications of diabetes and obesityJuly 2009
* JDRF Partner Bayhill Enters Collaboration with Genentech to Develop Type 1 Vaccine
June 2009
* Progress on the Stem Cell Front
* A Gene in Mice May Hold Clues to Treatments for People
* In the Near Future, a Clinical Trial of Regulatory T Cells
April 2009
* News in Islet Transplantation
* Cancer Drugs Reverse Diabetes in Mice
* A Potential New Treatment for Retinopathy
March 2009
* Stem cell policy repealed
* A promising new therapy
* Metabolic abnormalities precede autoimmunity in type 1 children
* Scientists find a way to encourage the replication of adult human beta cells
February 2009
* An important new field of study: the epigenetics of type 1 diabetes
* A new gastrin combination therapy reverses diabetes in mice
* Type 1 diabetes and celiac disease are genetically linked
December 2008
* JDRF-Funded Study Links "Hygiene Hypothesis" to Diabetes Prevention
* Diabetes Researchers Discover An Early Trigger of Autoimmunity
* A New Antigen Therapy Brings Long-Term Survival of Transplanted Islets Without Immunosuppression
September 2008
* In Mice, Adult Pancreas Cells are Made to Produce Insulin
* Interleukin-2 Emerges as a Central Player in the Development of Type 1 Diabetes
* Extension of the Special Diabetes Program
July 2008
* Towards Evaluating Pancreatic Beta Cells In Vivo
* Using Dendritic Cells to Control Autoimmunity
* Scientific Presentations Focus on Adults with Type 1 Diabetes
May 2008
* Success in Growing Human Beta Cells In Vitro
* An Antibody Therapy Activates Key Regulatory Cells, Alters Disease Progression
* Human Stem Cells, When Transplanted Into Mice, Are Fully Functional
March 2008
* An "Inflammatory Signature" in Both New-Onset and At-Risk Patients
* Genetics Protects Some From Diabetic Kidney Disease
* At Last, the Elusive Pancreatic Progenitor Cell
November 2007
* Tumor-Suppressing Protein Found to Regulate Beta Cell Growth
* Human Skin Cells Reprogrammed to Embryonic State
October 2007
* JDRF Industry Partners in Drug Development Alliances with Major Pharma
Companies
* Fatty Acid In Diet May Lower Type 1 Diabetes Risk
* Current Transplant Drugs May Hinder Beta Cell Regeneration
* Discovery of Fourth Diabetes Antibody Should Aid Prediction
September 2007
* Taking Antibody Orally May Block Diabetes
* Stopping Islet Inflammation May Be Key for Type 1 Prevention
* Gene Provides Clues to Development of Type 1
July 2007
* Study Finds Type 1 Incidence May Be Higher Than Thought
* Mouse Skin Cells Reprogrammed to Embryonic State
* Powerful Research Method Finds Four New Type 1 Diabetes Genetic Regions
March 2007
* Clinical Trial of Diabetes Regenerative Therapy Shows Positive Results
* Glucagon May Add Another Dimension to Artificial Pancreas
* Immune System Pathway May Be Key Route for Preventing Diabetes
January 2007
* Natural Compounds Prevent Diabetes by Blocking Immune Cell Channel
* Amniotic-Fluid Derived Stem Cells Show Potential
* Drug Shown to Prevent Against Diabetic Retinopathy
2006 Archives >>
